These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The incidences of benign prostatic hyperplasia and prostatic cancer in China]. Gu FL Zhonghua Wai Ke Za Zhi; 1993 Jun; 31(6):323-6. PubMed ID: 7508844 [TBL] [Abstract][Full Text] [Related]
4. The epidemiology of prostate cancer part I: descriptive epidemiology. Brawley OW; Knopf K; Merrill R Semin Urol Oncol; 1998 Nov; 16(4):187-92. PubMed ID: 9858324 [TBL] [Abstract][Full Text] [Related]
5. Incidence of carcinoma prostate. A five year survey. Matapurkar BG; Taneja OP Indian J Cancer; 1969 Sep; 6(3):172-83. PubMed ID: 4186774 [No Abstract] [Full Text] [Related]
6. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study. Stamatiou K; Alevizos A; Agapitos E; Sofras F Prostate; 2006 Sep; 66(12):1319-28. PubMed ID: 16688747 [TBL] [Abstract][Full Text] [Related]
8. Future benefits and cost-effectiveness of prostate carcinoma screening. American Cancer Society. Littrup PJ Cancer; 1997 Nov; 80(9):1864-70. PubMed ID: 9351561 [TBL] [Abstract][Full Text] [Related]
9. Chronological changes in latent prostatic carcinoma found in surgical specimens from Japanese during 28 years. Komatsu H; Horiuchi S; Nakazawa H; Oyamatsu T; Nakagawa K; Yoshino S; Fujime M Jpn J Clin Oncol; 1983 Jun; 13(2):411-5. PubMed ID: 6887559 [TBL] [Abstract][Full Text] [Related]
10. The evaluation and treatment of BPH, 2002. Stein B Med Health R I; 2002 May; 85(5):153-5. PubMed ID: 12048748 [No Abstract] [Full Text] [Related]
11. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China. Gu F Chin Med J (Engl); 2000 Apr; 113(4):299-302. PubMed ID: 11775222 [TBL] [Abstract][Full Text] [Related]
13. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691 [TBL] [Abstract][Full Text] [Related]
14. Benign prostatic hyperplasia, prostate cancer and other prostate diseases diagnosed as a result of screening procedure among 1,004 men in the Lublin district. Opalińska E; Stoma F; Michalak A; Latalski M; Goniewicz M Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):493-501. PubMed ID: 12898966 [TBL] [Abstract][Full Text] [Related]
15. [Cancer of the prostate. 1. Epidemiology]. Mottet Auselo N; Costa P; Le Pellec L; Louis JF; Navratil H Prog Urol; 1995 Feb; 5(1):31-7. PubMed ID: 7536526 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of latent prostate carcinoma in two U.S. populations. Guileyardo JM; Johnson WD; Welsh RA; Akazaki K; Correa P J Natl Cancer Inst; 1980 Aug; 65(2):311-6. PubMed ID: 6931251 [TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of prostatic cancer]. Harvei S Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3589-94. PubMed ID: 10563177 [TBL] [Abstract][Full Text] [Related]
18. Prostatic tumours in Benin City, Nigeria. Akang EE; Aligbe JU; Olisa EG West Afr J Med; 1996; 15(1):56-60. PubMed ID: 8652442 [TBL] [Abstract][Full Text] [Related]
19. Incidence of prostatic cancer in Japan and Asia. Niijima T; Koiso K Scand J Urol Nephrol Suppl; 1980; 55():17-21. PubMed ID: 6938022 [TBL] [Abstract][Full Text] [Related]
20. Interpreting recent trends in prostate cancer incidence and mortality. Gann PH Epidemiology; 1997 Mar; 8(2):117-20. PubMed ID: 9229198 [No Abstract] [Full Text] [Related] [Next] [New Search]